Does Haemonetics' (HAE) Hospital Rebound and NexSys Expansion Reframe Its Competitive Positioning?

In recent months, Haemonetics has reported a recovery in its Hospital division, supported by broader adoption of its ...
Nasdaq

Haemonetics (HAE) Banks on Growing Hospital Arm, New Launches

Haemonetics HAE has been benefiting from business growth within Plasma, Hospital and Hemostasis Management. New launches are also aiding growth. The stock carries a Zacks Rank #1 (Strong Buy).